Buy Rating for Amgen: Strong Growth Prospects Driven by …

Oct 15, 2024 · Nico Chen has given his Buy rating due to a combination of factors including Amgen’s consistent performance in launching blockbuster drugs and positive clinical trial data, as well as strategic ...

CouponFollow Extension

$362.00
OFF

Amgen’s Strategic Shift And Strong Pipeline Drive Buy Rating

2 weeks from now

Jan 14, 2025 · Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Amgen (AMGN – Research Report), retaining the price target of $362.00. Discover outperforming …

businessinsider.com

0%
OFF

Strong Buy Rating For Amgen Amidst Impressive Growth And …

2 weeks from now

Oct 30, 2024 · These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks , Werber is a 5-star analyst with an average return of 14.0% and …

businessinsider.com

$380.00
OFF

What Analysts Are Saying About Amgen Stock | Nasdaq

2 weeks from now

Nov 14, 2024 · Analysts' ratings for Amgen (NASDAQ: ... Buy: $380.00: $380.00: Colin Bristow: UBS: Lowers: Neutral: ... Revenue Growth: Amgen's revenue growth over a period of 3 …

nasdaq.com

$370.00
OFF

Goldman Sachs Retains Amgen Buy Stock Rating On Clinical Trial

2 weeks from now

Jan 15, 2025 · On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ:AMGN), maintaining a price target of $370.00. The biotechnology giant, with a …

investing.com

$12
OFF

Amgen's Broad Portfolio Strength And Wide Moat Should

2 weeks from now

2 days ago · At the end of 2024, Amgen held $12 billion in cash and $60 billion in debt, with higher debt levels driven by the 2023 Horizon acquisition. Given its strong free cash flows, we …

morningstar.com

20%
OFF

Amgen Faces Near-Term Challenges But Long-Term Growth …

2 weeks from now

Aug 7, 2024 · On Tuesday, Amgen Inc. (NASDAQ:AMGN) reported second-quarter sales of $8.39 billion, up 20% year over year and beating the consensus of $8.33 billion. Product sales grew …

yahoo.com

20%
OFF

Amgen Faces Near-Term Challenges But Long-Term Growth …

2 weeks from now

Aug 7, 2024 · On Tuesday, Amgen Inc. AMGN reported second-quarter sales of $8.39 billion, up 20% year over year and beating the consensus of $8.33 billion. Product sales grew 20%, …

benzinga.com

23%
OFF

Are Wall Street Analysts Predicting Amgen Stock Will Climb Or Sink?

2 weeks from now

3 days ago · The revenue growth of 23% year-over-year to $8.5 billion, driven by higher product sales, also helped boost investor sentiment, particularly the strong performance of drugs like …

nasdaq.com

$314.55
OFF

Expert Ratings For Amgen - Nasdaq

2 weeks from now

Jun 14, 2024 · Analysts have recently evaluated Amgen and provided 12-month price targets. The average target is $314.55, accompanied by a high estimate of $360.00 and a low estimate of …

nasdaq.com

05%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024 · While Amgen's (AMGN 0.05%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

8%
OFF

Why Amgen Inc. (AMGN) Is The Best Safe Stock To Buy According …

2 weeks from now

Dec 12, 2024 · We then referred to the 10-year revenue growth rate for each stock and a solid analyst upside, of at least 8%. The 10 safe stocks to buy according to analysts are in …

yahoo.com

$320
OFF

RBC Capital Cuts Amgen Stock Price Target To $320 From $324

2 weeks from now

3 days ago · For deeper insights into Amgen's financial health and growth prospects, InvestingPro subscribers can access the comprehensive Pro Research Report, which covers what really …

investing.com

25%
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

The company's strong performance is reflected in its 21.25% revenue growth over the last twelve months. According to Erste Group analysts, Amgen is expected to maintain an upward …

msn.com

11%
OFF

Amgen Impresses With Q4 Earnings Beat, Analysts See Growth …

2 weeks from now

2 days ago · On Tuesday, Amgen Inc AMGN reported fourth-quarter sales of $9.10 billion, up 11% year-over-year, beating the consensus of $8.9 billion. Product sales grew 11%, primarily …

benzinga.com

$383.00
OFF

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024 · TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00. Yaron Wer...

businessinsider.com

$275.00
OFF

Cautious Outlook On Amgen: Sell Rating Amid Modest Growth

2 weeks from now

1 day ago · In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a price target of $275.00. Maximize …

tipranks.com

50%
OFF

Amgen Inc.'s Stock Price Soars To $307.81, Marking A Robust 6.50% ...

2 weeks from now

2 days ago · Amgen Inc. on Smartkarma. Analysts at Baptista Research have been closely monitoring Amgen Inc‘s recent financial results and pipeline advancements. In the third quarter …

smartkarma.com

93%
OFF

Corning Q4: Accelerating Growth Supports Buy Rating

2 weeks from now

23 hours ago · Here, Enterprise Network was the biggest growth contributor, with a 93% increase in sales, driven by "strong adoption of our new generative AI products." These are mostly …

seekingalpha.com

$328
OFF

Amgen Price Target Raised To $328 From $322 At Morgan Stanley

2 weeks from now

2 days ago · Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen to $328 from $322 and keeps an Equal Weight rating on the shares.Amgen posted a Q4 beat …

businessinsider.com

FAQs about Buy Rating for Amgen: Strong Growth Prospects Driven by … Coupon?

Is Amgen (AMGN) a good stock to buy?

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen (AMGN) to $328 from $322 and keeps an Equal Weight rating on the shares. Amgen posted a Q4 beat and gave 2025 revenue and EPS guidance that bracketed consensus, which the firm views as a positive given questions ahead of the quarter, the analyst tells investors. ...

Is Amgen a good stock to buy ahead of Q4?

Amgen posted a Q4 beat and gave 2025 revenue and EPS guidance that bracketed consensus, which the firm views as a positive given questions ahead of the quarter, the analyst tells investors. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. ...

Should you buy biotech heavyweight Amgen (Amgen)?

Buying and holding stocks for long periods of time can generate market-beating results. Most individual stocks, however, aren't capable of delivering above-average results over the long haul. Biotech heavyweight Amgen may be one of the few exceptions. ...

Should you buy Amgen (AMGN -0.09%) as a dividend-paying Biotech stock?

One way to increase your odds of success is to buy shares of high-quality companies that sport strong competitive advantages, solid growth prospects, and attractive valuations. Biotech giant Amgen ( AMGN -0.09%) ticks many of these boxes. Read on to find out more about this top dividend-paying biotech stock. ...

Is Amgen (Amgen) a good dividend stock?

Despite Amgen's rising share price, the dividend yield is still above its 5-year average of 3.07%. The forward yield is now about 3.1% after the recent price gain after earnings were reported. This implies a slightly undervalued to fairly valued equity. Amgen is a Dividend Contender with a 14-year streak of increases. ...

Should you invest in Amgen?

Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new cardiometabolic medicines for big-ticket indications like obesity and type 2 diabetes, there is still a big reason to be slightly cautious with an investment. ...